Trimethoprim-associated hyponatremia

Revekka Babayev, Sofia Terner, Subani Chandra, Jai Radhakrishnan, Sumit Mohan

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Hyponatremia associated with diuretic use can be clinically difficult to differentiate from the syndrome of inappropriate antidiuretic hormone secretion (SIADH). We report a case of a 28-year-old man with HIV (human immunodeficiency virus) and Pneumocystis pneumonia who developed hyponatremia while receiving trimethoprim-sulfamethoxazole (TMP/SMX). Serum sodium level on admission was 135 mEq/L (with a history of hyponatremia) and decreased to 117 mEq/L by day 7 of TMP/SMX treatment. In the setting of suspected euvolemia and Pneumocystis pneumonia, he was treated initially for SIADH with fluid restriction and tolvaptan without improvement in serum sodium level. A diagnosis of hyponatremia secondary to the diuretic effect of TMP subsequently was confirmed, with clinical hypovolemia and high renin, aldosterone, and urinary sodium levels. Subsequent therapy with sodium chloride stabilized serum sodium levels in the 126- to 129-mEq/L range. After discontinuation of TMP/SMX treatment, serum sodium, renin, and aldosterone levels normalized. TMP/SMX-related hyponatremia likely is underdiagnosed and often mistaken for SIADH. It should be considered for patients on high-dose TMP/SMX treatment and can be differentiated from SIADH by clinical hypovolemia (confirmed by high renin and aldosterone levels). TMP-associated hyponatremia can be treated with sodium supplementation to offset ongoing urinary losses if the TMP/SMX therapy cannot be discontinued. In this Acid-Base and Electrolyte Teaching Case, a less common cause of hyponatremia is presented, and a stepwise approach to the diagnosis is illustrated.

Original languageEnglish (US)
Pages (from-to)1188-1192
Number of pages5
JournalAmerican Journal of Kidney Diseases
Volume62
Issue number6
DOIs
StatePublished - Dec 2013
Externally publishedYes

Fingerprint

Trimethoprim
Hyponatremia
Sulfamethoxazole Drug Combination Trimethoprim
Inappropriate ADH Syndrome
Sodium
Aldosterone
Renin
Thymidine Monophosphate
Hypovolemia
Pneumocystis Pneumonia
Serum
Diuretics
Therapeutics
Sodium Chloride
Electrolytes
Teaching
HIV
Acids

Keywords

  • epithelial Na channel (eNaC)
  • Hyponatremia
  • renal salt wasting
  • syndrome of inappropriate antidiuretic hormone secretion (SIADH)
  • trimethroprim

ASJC Scopus subject areas

  • Nephrology
  • Medicine(all)

Cite this

Babayev, R., Terner, S., Chandra, S., Radhakrishnan, J., & Mohan, S. (2013). Trimethoprim-associated hyponatremia. American Journal of Kidney Diseases, 62(6), 1188-1192. https://doi.org/10.1053/j.ajkd.2013.06.007

Trimethoprim-associated hyponatremia. / Babayev, Revekka; Terner, Sofia; Chandra, Subani; Radhakrishnan, Jai; Mohan, Sumit.

In: American Journal of Kidney Diseases, Vol. 62, No. 6, 12.2013, p. 1188-1192.

Research output: Contribution to journalArticle

Babayev, R, Terner, S, Chandra, S, Radhakrishnan, J & Mohan, S 2013, 'Trimethoprim-associated hyponatremia', American Journal of Kidney Diseases, vol. 62, no. 6, pp. 1188-1192. https://doi.org/10.1053/j.ajkd.2013.06.007
Babayev R, Terner S, Chandra S, Radhakrishnan J, Mohan S. Trimethoprim-associated hyponatremia. American Journal of Kidney Diseases. 2013 Dec;62(6):1188-1192. https://doi.org/10.1053/j.ajkd.2013.06.007
Babayev, Revekka ; Terner, Sofia ; Chandra, Subani ; Radhakrishnan, Jai ; Mohan, Sumit. / Trimethoprim-associated hyponatremia. In: American Journal of Kidney Diseases. 2013 ; Vol. 62, No. 6. pp. 1188-1192.
@article{00d04c6c09f04b779dcd87c1efabcf40,
title = "Trimethoprim-associated hyponatremia",
abstract = "Hyponatremia associated with diuretic use can be clinically difficult to differentiate from the syndrome of inappropriate antidiuretic hormone secretion (SIADH). We report a case of a 28-year-old man with HIV (human immunodeficiency virus) and Pneumocystis pneumonia who developed hyponatremia while receiving trimethoprim-sulfamethoxazole (TMP/SMX). Serum sodium level on admission was 135 mEq/L (with a history of hyponatremia) and decreased to 117 mEq/L by day 7 of TMP/SMX treatment. In the setting of suspected euvolemia and Pneumocystis pneumonia, he was treated initially for SIADH with fluid restriction and tolvaptan without improvement in serum sodium level. A diagnosis of hyponatremia secondary to the diuretic effect of TMP subsequently was confirmed, with clinical hypovolemia and high renin, aldosterone, and urinary sodium levels. Subsequent therapy with sodium chloride stabilized serum sodium levels in the 126- to 129-mEq/L range. After discontinuation of TMP/SMX treatment, serum sodium, renin, and aldosterone levels normalized. TMP/SMX-related hyponatremia likely is underdiagnosed and often mistaken for SIADH. It should be considered for patients on high-dose TMP/SMX treatment and can be differentiated from SIADH by clinical hypovolemia (confirmed by high renin and aldosterone levels). TMP-associated hyponatremia can be treated with sodium supplementation to offset ongoing urinary losses if the TMP/SMX therapy cannot be discontinued. In this Acid-Base and Electrolyte Teaching Case, a less common cause of hyponatremia is presented, and a stepwise approach to the diagnosis is illustrated.",
keywords = "epithelial Na channel (eNaC), Hyponatremia, renal salt wasting, syndrome of inappropriate antidiuretic hormone secretion (SIADH), trimethroprim",
author = "Revekka Babayev and Sofia Terner and Subani Chandra and Jai Radhakrishnan and Sumit Mohan",
year = "2013",
month = "12",
doi = "10.1053/j.ajkd.2013.06.007",
language = "English (US)",
volume = "62",
pages = "1188--1192",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Trimethoprim-associated hyponatremia

AU - Babayev, Revekka

AU - Terner, Sofia

AU - Chandra, Subani

AU - Radhakrishnan, Jai

AU - Mohan, Sumit

PY - 2013/12

Y1 - 2013/12

N2 - Hyponatremia associated with diuretic use can be clinically difficult to differentiate from the syndrome of inappropriate antidiuretic hormone secretion (SIADH). We report a case of a 28-year-old man with HIV (human immunodeficiency virus) and Pneumocystis pneumonia who developed hyponatremia while receiving trimethoprim-sulfamethoxazole (TMP/SMX). Serum sodium level on admission was 135 mEq/L (with a history of hyponatremia) and decreased to 117 mEq/L by day 7 of TMP/SMX treatment. In the setting of suspected euvolemia and Pneumocystis pneumonia, he was treated initially for SIADH with fluid restriction and tolvaptan without improvement in serum sodium level. A diagnosis of hyponatremia secondary to the diuretic effect of TMP subsequently was confirmed, with clinical hypovolemia and high renin, aldosterone, and urinary sodium levels. Subsequent therapy with sodium chloride stabilized serum sodium levels in the 126- to 129-mEq/L range. After discontinuation of TMP/SMX treatment, serum sodium, renin, and aldosterone levels normalized. TMP/SMX-related hyponatremia likely is underdiagnosed and often mistaken for SIADH. It should be considered for patients on high-dose TMP/SMX treatment and can be differentiated from SIADH by clinical hypovolemia (confirmed by high renin and aldosterone levels). TMP-associated hyponatremia can be treated with sodium supplementation to offset ongoing urinary losses if the TMP/SMX therapy cannot be discontinued. In this Acid-Base and Electrolyte Teaching Case, a less common cause of hyponatremia is presented, and a stepwise approach to the diagnosis is illustrated.

AB - Hyponatremia associated with diuretic use can be clinically difficult to differentiate from the syndrome of inappropriate antidiuretic hormone secretion (SIADH). We report a case of a 28-year-old man with HIV (human immunodeficiency virus) and Pneumocystis pneumonia who developed hyponatremia while receiving trimethoprim-sulfamethoxazole (TMP/SMX). Serum sodium level on admission was 135 mEq/L (with a history of hyponatremia) and decreased to 117 mEq/L by day 7 of TMP/SMX treatment. In the setting of suspected euvolemia and Pneumocystis pneumonia, he was treated initially for SIADH with fluid restriction and tolvaptan without improvement in serum sodium level. A diagnosis of hyponatremia secondary to the diuretic effect of TMP subsequently was confirmed, with clinical hypovolemia and high renin, aldosterone, and urinary sodium levels. Subsequent therapy with sodium chloride stabilized serum sodium levels in the 126- to 129-mEq/L range. After discontinuation of TMP/SMX treatment, serum sodium, renin, and aldosterone levels normalized. TMP/SMX-related hyponatremia likely is underdiagnosed and often mistaken for SIADH. It should be considered for patients on high-dose TMP/SMX treatment and can be differentiated from SIADH by clinical hypovolemia (confirmed by high renin and aldosterone levels). TMP-associated hyponatremia can be treated with sodium supplementation to offset ongoing urinary losses if the TMP/SMX therapy cannot be discontinued. In this Acid-Base and Electrolyte Teaching Case, a less common cause of hyponatremia is presented, and a stepwise approach to the diagnosis is illustrated.

KW - epithelial Na channel (eNaC)

KW - Hyponatremia

KW - renal salt wasting

KW - syndrome of inappropriate antidiuretic hormone secretion (SIADH)

KW - trimethroprim

UR - http://www.scopus.com/inward/record.url?scp=84888380186&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888380186&partnerID=8YFLogxK

U2 - 10.1053/j.ajkd.2013.06.007

DO - 10.1053/j.ajkd.2013.06.007

M3 - Article

C2 - 23891358

AN - SCOPUS:84888380186

VL - 62

SP - 1188

EP - 1192

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 6

ER -